Mitral valve regurgitation and left ventricular systolic dysfunction: corrective surgery or cardiac resynchronization therapy?
Mitral regurgitation (MR) can be found in a sizeable percentage of patients with chronic congestive heart failure (CHF) and systolic left ventricular (LV) dysfunction despite a structurally normal valve. This functional or secondary regurgitation results from a dysbalance between closing and opening forces on the mitral leaflets due to reduced LV contractility, geometric distortion of the subvalvular apparatus, and global dilatation of the left ventricle and the mitral annulus. MR in LV dysfunction has a negative impact on both symptoms and prognosis. Surgical correction of secondary MR remained controversial although it was found to be technically feasible and to provide symptomatic benefit in some (mostly) mono-center series. Cardiac resynchronization therapy (CRT) was also found to improve secondary mitral regurgitation. However, the prediction in which patient significant secondary MR will improve with CRT is largely unresolved. The following paper reviews the available data concerning the two major interventional options for significant secondary MR in patients with CHF and systolic LV dysfunction, i.e. mitral valve surgery vs. CRT, and describes our institutional approach to this problem.
Faber
L
L
Department of Cardiology, Heart and Diabetes Center NRW, Ruhr University Bochum, Georgstr. 11, 32545, Bad Oeynhausen, Germany. lfaber@hdz-nrw.de
Lamp
B
B
D002304:Cardiac Pacing, Artificial / Q000401:mortality*; D013504:Cardiovascular Surgical Procedures / Q000401:mortality*; D006333:Heart Failure / Q000401:mortality / Q000517:prevention & control; D006801:Humans; D015994:Incidence; D008944:Mitral Valve Insufficiency / Q000401:mortality* / Q000517:prevention & control*; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D018487:Ventricular Dysfunction, Left / Q000401:mortality* / Q000517:prevention & control*